"Potential benefits of pharmacogenomics technologies," by Huttin C and Vernon J, Electronic letter, Health Affairs, March 12, 2007.

In Response to Kathryn A. Phillips, "The Intersection Of Biotechnology And Pharmacogenomics: Health Policy Implications," Health Affairs, September/October 2006; 25(5): 1271-1280.

Click here to read the e-letter in full